Beyond the Scale: Psychological and Behavioural Considerations Following GLP‐1 Receptor Agonist Treatment Discontinuation

Alison K. Newman, Liana K. Billings
Diabetes, Obesity and Metabolism · Wiley · 2026-11-04 · DOI: 10.1111/dom.71536

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles